TW200633696A - Sesamin/episesamin compositions - Google Patents

Sesamin/episesamin compositions

Info

Publication number
TW200633696A
TW200633696A TW094147026A TW94147026A TW200633696A TW 200633696 A TW200633696 A TW 200633696A TW 094147026 A TW094147026 A TW 094147026A TW 94147026 A TW94147026 A TW 94147026A TW 200633696 A TW200633696 A TW 200633696A
Authority
TW
Taiwan
Prior art keywords
episesamin
sesamin
composition
sesamins
enhance
Prior art date
Application number
TW094147026A
Other languages
English (en)
Other versions
TWI368506B (zh
Inventor
Yoshiko Ono
Namino Tomimori
Saki Tokuda
Tomohiro Rogi
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of TW200633696A publication Critical patent/TW200633696A/zh
Application granted granted Critical
Publication of TWI368506B publication Critical patent/TWI368506B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
TW094147026A 2004-12-28 2005-12-28 Sesamin/episesamin compositions TW200633696A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004381806 2004-12-28
JP2004381726 2004-12-28

Publications (2)

Publication Number Publication Date
TW200633696A true TW200633696A (en) 2006-10-01
TWI368506B TWI368506B (zh) 2012-07-21

Family

ID=36614967

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094147026A TW200633696A (en) 2004-12-28 2005-12-28 Sesamin/episesamin compositions

Country Status (12)

Country Link
US (1) US20080275110A1 (zh)
EP (1) EP1842540A4 (zh)
JP (1) JP4995567B2 (zh)
KR (1) KR101244586B1 (zh)
CN (2) CN101849935B (zh)
AU (1) AU2005320579B2 (zh)
CA (1) CA2592532C (zh)
HK (2) HK1088333A1 (zh)
MY (1) MY148121A (zh)
SG (1) SG158183A1 (zh)
TW (1) TW200633696A (zh)
WO (1) WO2006070856A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006106926A1 (ja) 2005-03-31 2006-10-12 Suntory Limited リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds
JP5409989B2 (ja) * 2006-04-03 2014-02-05 サントリーホールディングス株式会社 セサミン類含有動物用飲食物
EP2070532B1 (en) * 2006-10-04 2013-07-24 Suntory Holdings Limited O/w/o emulsion containing lignan compounds, and composition containing the same
JP5276316B2 (ja) 2007-12-28 2013-08-28 サントリーホールディングス株式会社 セサミン類及びケルセチン配糖体を含有する組成物
CN101342148B (zh) * 2008-07-03 2012-09-05 姚英 一种速效抗菌消炎、抗病毒的超浓缩天然蒜素片及其制备方法
JP5547891B2 (ja) * 2008-12-26 2014-07-16 サントリーホールディングス株式会社 セサミン類とエピガロカテキンガレートとを含有する組成物
JP6157463B2 (ja) * 2012-06-14 2017-07-05 サントリーホールディングス株式会社 セサミン類とγ−オリザノールと米胚芽油とを含有する組成物
JP2015140315A (ja) * 2014-01-29 2015-08-03 中日本カプセル 株式会社 ソフトカプセル用の充填組成物
CN107405329B (zh) * 2015-03-23 2021-04-09 三得利控股株式会社 昼夜节律改善用组合物
WO2021065664A1 (ja) * 2019-10-04 2021-04-08 サントリーホールディングス株式会社 生活活動量の維持、低下予防、低下抑制又は改善用組成物
CN113812618A (zh) * 2020-06-18 2021-12-21 陈信行 腐植酸芝麻素复方及其制程

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211953A (en) * 1989-07-21 1993-05-18 Suntory, Limited Liver function improver
DK0409654T3 (da) * 1989-07-21 2001-12-27 Suntory Ltd Leverfunktionsforbedrende middel
JP3001589B2 (ja) * 1989-07-21 2000-01-24 サントリー株式会社 リグナン類含有飲食物
JP3075358B2 (ja) * 1990-04-03 2000-08-14 サントリー株式会社 肝機能改善剤
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
EP0782827B1 (en) * 1995-07-04 2003-10-01 Suntory Limited Use of a balancing agent for omega-6 and omega-3 unsaturated fatty acids
JP3205315B2 (ja) * 1999-04-28 2001-09-04 リノール油脂株式会社 ジオキサビシクロ〔３．３．０〕オクタン誘導体を有効成分とする体脂肪低減剤
EP1250052A1 (en) * 2000-01-25 2002-10-23 Juvenon, Inc. Nutritional supplements for aged pets

Also Published As

Publication number Publication date
EP1842540A4 (en) 2011-12-28
TWI368506B (zh) 2012-07-21
AU2005320579A1 (en) 2006-07-06
JP4995567B2 (ja) 2012-08-08
KR101244586B1 (ko) 2013-03-25
CN1796388A (zh) 2006-07-05
CA2592532C (en) 2015-02-17
HK1088333A1 (en) 2006-11-03
JPWO2006070856A1 (ja) 2008-06-12
WO2006070856A1 (ja) 2006-07-06
AU2005320579B2 (en) 2011-09-22
CN1796388B (zh) 2011-01-26
SG158183A1 (en) 2010-01-29
HK1148465A1 (en) 2011-09-09
EP1842540A1 (en) 2007-10-10
MY148121A (en) 2013-02-28
CN101849935B (zh) 2011-09-28
CN101849935A (zh) 2010-10-06
CA2592532A1 (en) 2006-07-06
US20080275110A1 (en) 2008-11-06
KR20070089752A (ko) 2007-08-31

Similar Documents

Publication Publication Date Title
TW200633696A (en) Sesamin/episesamin compositions
EP1736160A4 (en) OLIGOSACCHARIDES OF ALGINE AND DERIVATIVES THEREOF AND THEIR MANUFACTURE AND USE
EP2545939A3 (en) Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
IL183360A (en) 12-aryl prostaglandin analogs, compositions comprising them and their use in the preparation of medicaments
IL171170A (en) History of itensinoids and their pharmaceutical preparations, methods of preparation and use thereof
MY143795A (en) Tetrahydropyridoindole derivatives
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
IL169647A (en) Pyrimidines that inhibit HIV replication, use them to make pharmaceutical preparations and preparations containing them
ATE537828T1 (de) Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
ME01663B (me) Derivati N-(1H-indolil)-1H-indol-2-karboksamida, njihova priprema i njihova primena u terapiji
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
IL205350A0 (en) Novel 1, 3- dihydro - 5 - isobenzofurancarbonitrile derivatives and pharmacetical composition thereof for the treatment of premature ejaculation
WO2006068713A3 (en) 3,3'-diindolylmethane immune activating compositions
TW200505437A (en) Composition possessing autonomic nerve function regulating action and use thereof
WO2004006911A3 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
EP1783115A4 (en) ARYLAMINE KETONES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS WHICH THEY CONTAIN AND ITS APPLICATION
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
WO2003080568A3 (en) Probucol derivatives
PL1668021T3 (pl) Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie